Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The weekly trading volume of DEX on the Ethereum chain exceeds 9.8 billion US dollars, ranking first, with a 7-day increase of 6.26%

The weekly trading volume of DEX on the Ethereum chain exceeds 9.8 billion US dollars, ranking first, with a 7-day increase of 6.26%

Bitget2024/05/19 06:18

DeFiLlama data shows that the trading volume on Ethereum's DEX in the past 7 days was $9.872 billion, ranking first with a 7-day increase of 6.26%.

The trading volume on Solana's DEX in the past 7 days was $7.548 billion, with a 7-day increase of 4.91%.
The trading volume on BSC's DEX in the past 7 days was $4.47 billion, with a 7-day increase of 3.34%.
The trading volume on Arbitrum's DEX in the past 7 days was $2.723 billion, with a decrease of -3.81% over seven days.
The trading volume on Base chain’s DEX over the last seven days amounted to $2.474 billion, marking an increase by as much as18 .04%.

2
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The second wave of energy price increases is looming! European Central Bank’s Lane warns: eurozone inflation will be higher and more persistent

Philip Lane, Chief Economist of the European Central Bank, stated that a new round of high energy prices means inflation in the eurozone will remain elevated for longer than the ECB initially anticipated.

智通财经2026/09/22 07:56

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11